Drug companies must report #clinical #trial results, even when they won’t lead to a product, experts urge
in some cases development is terminated because regulatory agencies require additional studies and the company sponsoring the trial is unwilling to comply. Companies may also terminate a program because of a lack of resources or because of a “reevaluation of the market opportunity.”
Many sponsors do publish the results of their clinical trials even when there are no plans to market the product being tested, but there is no legal requirement that they do so.
(...) “scientific information on the efficacy — or lack of efficacy — and safety — or lack of safety — of the investigational agents is not available to the research community, and the opportunity to learn from unsuccessful clinical trials is eliminated,”